<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2025, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Fri, 14 Mar 2025 12:40:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>New to The Street &amp; Sight &amp; Sound's Visionaries Series Premieres Tomorrow on Bloomberg at 6:30 PM EST, Featuring Acurx Pharmaceuticals NASDAQ:ACXP</title>
   <link>http://www.streetinsider.com/Press+Releases/New+to+The+Street+%26+Sight+%26+Sound%27s+Visionaries+Series+Premieres+Tomorrow+on+Bloomberg+at+6%3A30+PM+EST%2C+Featuring+Acurx+Pharmaceuticals+NASDAQ%3AACXP/24502230.html</link>
   <description>
      &lt;p&gt;&lt;strong id=&quot;dateline&quot;&gt;NEW YORK CITY, NEW YORK / &lt;a href='https://www.accessnewswire.com/'&gt;ACCESS Newswire&lt;/a&gt; / March 14, 2025 / &lt;/strong&gt;The highly anticipated &lt;strong&gt;Visionaries Series&lt;/strong&gt; from &lt;i&gt;New to The Street&lt;/i&gt; and &lt;i&gt;Sight &amp; Sound&lt;/i&gt; premieres tomorrow on &lt;strong&gt;Bloomberg at 6:30 PM EST as sponsored programming&lt;/strong&gt;, featuring &lt;strong&gt;Acurx Pharmaceuticals&lt;/strong&gt;. This compelling episode follows the incredible journey of &lt;strong&gt;co-founders David P. Luci, Robert J. DeLuccia, and Robert G. Shawah &lt;/strong&gt;- from their &lt;strong&gt;college days to building and exiting successful pharmaceutical companies&lt;/strong&gt;, and ultimately coming together to launch &lt;strong&gt;Acurx Pharmaceuticals&lt;/strong&gt;.&lt;/p&gt;&lt;p&gt;The series explores the &lt;strong&gt;vision, perseverance, and expertise&lt;/strong&gt; that led them to develop</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/New+to+The+Street+%26+Sight+%26+Sound%27s+Visionaries+Series+Premieres+Tomorrow+on+Bloomberg+at+6%3A30+PM+EST%2C+Featuring+Acurx+Pharmaceuticals+NASDAQ%3AACXP/24502230.html</guid>
   <pubDate>Fri, 14 Mar 2025 12:40:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DPRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PLXP</category>
   	  </item>
  <item>
   <title>New to The Street &amp; Sight &amp; Sound's Visionaries Series Premieres Tomorrow on Bloomberg at 6:30 PM EST, Featuring Acurx Pharmaceuticals NASDAQ:ACXP</title>
   <link>http://www.streetinsider.com/ACCESS+Newswire/New+to+The+Street+%26+Sight+%26+Sound%27s+Visionaries+Series+Premieres+Tomorrow+on+Bloomberg+at+6%3A30+PM+EST%2C+Featuring+Acurx+Pharmaceuticals+NASDAQ%3AACXP/24502230.html</link>
   <description>
      &lt;p&gt;&lt;strong id=&quot;dateline&quot;&gt;NEW YORK CITY, NEW YORK / &lt;a href='https://www.accessnewswire.com/'&gt;ACCESS Newswire&lt;/a&gt; / March 14, 2025 / &lt;/strong&gt;The highly anticipated &lt;strong&gt;Visionaries Series&lt;/strong&gt; from &lt;i&gt;New to The Street&lt;/i&gt; and &lt;i&gt;Sight &amp; Sound&lt;/i&gt; premieres tomorrow on &lt;strong&gt;Bloomberg at 6:30 PM EST as sponsored programming&lt;/strong&gt;, featuring &lt;strong&gt;Acurx Pharmaceuticals&lt;/strong&gt;. This compelling episode follows the incredible journey of &lt;strong&gt;co-founders David P. Luci, Robert J. DeLuccia, and Robert G. Shawah &lt;/strong&gt;- from their &lt;strong&gt;college days to building and exiting successful pharmaceutical companies&lt;/strong&gt;, and ultimately coming together to launch &lt;strong&gt;Acurx Pharmaceuticals&lt;/strong&gt;.&lt;/p&gt;&lt;p&gt;The series explores the &lt;strong&gt;vision, perseverance, and expertise&lt;/strong&gt; that led them to develop</description>
   <guid isPermaLink="true">http://www.streetinsider.com/ACCESS+Newswire/New+to+The+Street+%26+Sight+%26+Sound%27s+Visionaries+Series+Premieres+Tomorrow+on+Bloomberg+at+6%3A30+PM+EST%2C+Featuring+Acurx+Pharmaceuticals+NASDAQ%3AACXP/24502230.html</guid>
   <pubDate>Fri, 14 Mar 2025 12:40:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DPRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PLXP</category>
   	  </item>
  <item>
   <title>New to The Street &amp; Sight &amp; Sound's Visionaries Series Premieres Tomorrow on Bloomberg at 6:30 PM EST, Featuring Acurx Pharmaceuticals NASDAQ:ACXP</title>
   <link>http://www.streetinsider.com/Press+Releases/New+to+The+Street+%26+Sight+%26+Sound%27s+Visionaries+Series+Premieres+Tomorrow+on+Bloomberg+at+6%3A30+PM+EST%2C+Featuring+Acurx+Pharmaceuticals+NASDAQ%3AACXP/24502230.html</link>
   <description>
      &lt;p&gt;&lt;strong id=&quot;dateline&quot;&gt;NEW YORK CITY, NEW YORK / &lt;a href='https://www.accessnewswire.com/'&gt;ACCESS Newswire&lt;/a&gt; / March 14, 2025 / &lt;/strong&gt;The highly anticipated &lt;strong&gt;Visionaries Series&lt;/strong&gt; from &lt;i&gt;New to The Street&lt;/i&gt; and &lt;i&gt;Sight &amp; Sound&lt;/i&gt; premieres tomorrow on &lt;strong&gt;Bloomberg at 6:30 PM EST as sponsored programming&lt;/strong&gt;, featuring &lt;strong&gt;Acurx Pharmaceuticals&lt;/strong&gt;. This compelling episode follows the incredible journey of &lt;strong&gt;co-founders David P. Luci, Robert J. DeLuccia, and Robert G. Shawah &lt;/strong&gt;- from their &lt;strong&gt;college days to building and exiting successful pharmaceutical companies&lt;/strong&gt;, and ultimately coming together to launch &lt;strong&gt;Acurx Pharmaceuticals&lt;/strong&gt;.&lt;/p&gt;&lt;p&gt;The series explores the &lt;strong&gt;vision, perseverance, and expertise&lt;/strong&gt; that led them to develop</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/New+to+The+Street+%26+Sight+%26+Sound%27s+Visionaries+Series+Premieres+Tomorrow+on+Bloomberg+at+6%3A30+PM+EST%2C+Featuring+Acurx+Pharmaceuticals+NASDAQ%3AACXP/24502230.html</guid>
   <pubDate>Fri, 14 Mar 2025 12:40:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DPRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PLXP</category>
   	  </item>
  <item>
   <title>New to The Street &amp; Sight &amp; Sound's Visionaries Series Premieres Tomorrow on Bloomberg at 6:30 PM EST, Featuring Acurx Pharmaceuticals NASDAQ:ACXP</title>
   <link>http://www.streetinsider.com/ACCESS+Newswire/New+to+The+Street+%26+Sight+%26+Sound%27s+Visionaries+Series+Premieres+Tomorrow+on+Bloomberg+at+6%3A30+PM+EST%2C+Featuring+Acurx+Pharmaceuticals+NASDAQ%3AACXP/24502230.html</link>
   <description>
      &lt;p&gt;&lt;strong id=&quot;dateline&quot;&gt;NEW YORK CITY, NEW YORK / &lt;a href='https://www.accessnewswire.com/'&gt;ACCESS Newswire&lt;/a&gt; / March 14, 2025 / &lt;/strong&gt;The highly anticipated &lt;strong&gt;Visionaries Series&lt;/strong&gt; from &lt;i&gt;New to The Street&lt;/i&gt; and &lt;i&gt;Sight &amp; Sound&lt;/i&gt; premieres tomorrow on &lt;strong&gt;Bloomberg at 6:30 PM EST as sponsored programming&lt;/strong&gt;, featuring &lt;strong&gt;Acurx Pharmaceuticals&lt;/strong&gt;. This compelling episode follows the incredible journey of &lt;strong&gt;co-founders David P. Luci, Robert J. DeLuccia, and Robert G. Shawah &lt;/strong&gt;- from their &lt;strong&gt;college days to building and exiting successful pharmaceutical companies&lt;/strong&gt;, and ultimately coming together to launch &lt;strong&gt;Acurx Pharmaceuticals&lt;/strong&gt;.&lt;/p&gt;&lt;p&gt;The series explores the &lt;strong&gt;vision, perseverance, and expertise&lt;/strong&gt; that led them to develop</description>
   <guid isPermaLink="true">http://www.streetinsider.com/ACCESS+Newswire/New+to+The+Street+%26+Sight+%26+Sound%27s+Visionaries+Series+Premieres+Tomorrow+on+Bloomberg+at+6%3A30+PM+EST%2C+Featuring+Acurx+Pharmaceuticals+NASDAQ%3AACXP/24502230.html</guid>
   <pubDate>Fri, 14 Mar 2025 12:40:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DPRX</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">PLXP</category>
   	  </item>
  <item>
   <title>Form  4          PLx Pharma Inc.           For: Jan 17  Filed by: LUCI DAVID P</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PLx+Pharma+Inc.+++++++++++For%3A+Jan+17++Filed+by%3A+LUCI+DAVID+P/12802898.html</link>
   <description>si-local-file:///var/storage/secattach/20170421/12802898.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PLx+Pharma+Inc.+++++++++++For%3A+Jan+17++Filed+by%3A+LUCI+DAVID+P/12802898.html</guid>
   <pubDate>Fri, 21 Apr 2017 21:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DPRX</category>
   	  </item>
  <item>
   <title>Form  4          PLx Pharma Inc.           For: Apr 19  Filed by: MOSSMAN GARY L</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PLx+Pharma+Inc.+++++++++++For%3A+Apr+19++Filed+by%3A+MOSSMAN+GARY+L/12799167.html</link>
   <description>si-local-file:///var/storage/secattach/20170420/12799167.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PLx+Pharma+Inc.+++++++++++For%3A+Apr+19++Filed+by%3A+MOSSMAN+GARY+L/12799167.html</guid>
   <pubDate>Thu, 20 Apr 2017 21:18:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DPRX</category>
   	  </item>
  <item>
   <title>Form  4          PLx Pharma Inc.           For: Apr 19  Filed by: Valentino Michael J</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PLx+Pharma+Inc.+++++++++++For%3A+Apr+19++Filed+by%3A+Valentino+Michael+J/12799168.html</link>
   <description>si-local-file:///var/storage/secattach/20170420/12799168.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PLx+Pharma+Inc.+++++++++++For%3A+Apr+19++Filed+by%3A+Valentino+Michael+J/12799168.html</guid>
   <pubDate>Thu, 20 Apr 2017 21:18:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DPRX</category>
   	  </item>
  <item>
   <title>Form  4          PLx Pharma Inc.           For: Apr 19  Filed by: HADDEN JOHN</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PLx+Pharma+Inc.+++++++++++For%3A+Apr+19++Filed+by%3A+HADDEN+JOHN/12799165.html</link>
   <description>si-local-file:///var/storage/secattach/20170420/12799165.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PLx+Pharma+Inc.+++++++++++For%3A+Apr+19++Filed+by%3A+HADDEN+JOHN/12799165.html</guid>
   <pubDate>Thu, 20 Apr 2017 21:17:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DPRX</category>
   	  </item>
  <item>
   <title>Form  4          PLx Pharma Inc.           For: Apr 19  Filed by: JORDEN DAVID EMERSON</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PLx+Pharma+Inc.+++++++++++For%3A+Apr+19++Filed+by%3A+JORDEN+DAVID+EMERSON/12799166.html</link>
   <description>si-local-file:///var/storage/secattach/20170420/12799166.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PLx+Pharma+Inc.+++++++++++For%3A+Apr+19++Filed+by%3A+JORDEN+DAVID+EMERSON/12799166.html</guid>
   <pubDate>Thu, 20 Apr 2017 21:17:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DPRX</category>
   	  </item>
  <item>
   <title>Form  4          PLx Pharma Inc.           For: Apr 19  Filed by: Casale Robert</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PLx+Pharma+Inc.+++++++++++For%3A+Apr+19++Filed+by%3A+Casale+Robert/12799163.html</link>
   <description>si-local-file:///var/storage/secattach/20170420/12799163.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PLx+Pharma+Inc.+++++++++++For%3A+Apr+19++Filed+by%3A+Casale+Robert/12799163.html</guid>
   <pubDate>Thu, 20 Apr 2017 21:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DPRX</category>
   	  </item>
  <item>
   <title>Form  4          PLx Pharma Inc.           For: Apr 19  Filed by: Giordano Natasha</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PLx+Pharma+Inc.+++++++++++For%3A+Apr+19++Filed+by%3A+Giordano+Natasha/12799164.html</link>
   <description>si-local-file:///var/storage/secattach/20170420/12799164.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PLx+Pharma+Inc.+++++++++++For%3A+Apr+19++Filed+by%3A+Giordano+Natasha/12799164.html</guid>
   <pubDate>Thu, 20 Apr 2017 21:16:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DPRX</category>
   	  </item>
  <item>
   <title>Form  4          PLx Pharma Inc.           For: Apr 19  Filed by: CALHOUN KIRK K</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PLx+Pharma+Inc.+++++++++++For%3A+Apr+19++Filed+by%3A+CALHOUN+KIRK+K/12799162.html</link>
   <description>si-local-file:///var/storage/secattach/20170420/12799162.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PLx+Pharma+Inc.+++++++++++For%3A+Apr+19++Filed+by%3A+CALHOUN+KIRK+K/12799162.html</guid>
   <pubDate>Thu, 20 Apr 2017 21:15:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DPRX</category>
   	  </item>
  <item>
   <title>Form  4          PLx Pharma Inc.           For: Apr 19  Filed by: Balkema Gary S.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PLx+Pharma+Inc.+++++++++++For%3A+Apr+19++Filed+by%3A+Balkema+Gary+S./12799161.html</link>
   <description>si-local-file:///var/storage/secattach/20170420/12799161.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++PLx+Pharma+Inc.+++++++++++For%3A+Apr+19++Filed+by%3A+Balkema+Gary+S./12799161.html</guid>
   <pubDate>Thu, 20 Apr 2017 21:14:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DPRX</category>
   	  </item>
  <item>
   <title>Form  3          PLx Pharma Inc.           For: Apr 19  Filed by: Valentino Michael J</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++3++++++++++PLx+Pharma+Inc.+++++++++++For%3A+Apr+19++Filed+by%3A+Valentino+Michael+J/12799157.html</link>
   <description>si-local-file:///var/storage/secattach/20170420/12799157.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++3++++++++++PLx+Pharma+Inc.+++++++++++For%3A+Apr+19++Filed+by%3A+Valentino+Michael+J/12799157.html</guid>
   <pubDate>Thu, 20 Apr 2017 21:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DPRX</category>
   	  </item>
  <item>
   <title>Form  3          PLx Pharma Inc.           For: Apr 19  Filed by: Giordano Natasha</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++3++++++++++PLx+Pharma+Inc.+++++++++++For%3A+Apr+19++Filed+by%3A+Giordano+Natasha/12799158.html</link>
   <description>si-local-file:///var/storage/secattach/20170420/12799158.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++3++++++++++PLx+Pharma+Inc.+++++++++++For%3A+Apr+19++Filed+by%3A+Giordano+Natasha/12799158.html</guid>
   <pubDate>Thu, 20 Apr 2017 21:06:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DPRX</category>
   	  </item>
  <item>
   <title>Form  3          PLx Pharma Inc.           For: Apr 19  Filed by: MOSSMAN GARY L</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++3++++++++++PLx+Pharma+Inc.+++++++++++For%3A+Apr+19++Filed+by%3A+MOSSMAN+GARY+L/12799155.html</link>
   <description>si-local-file:///var/storage/secattach/20170420/12799155.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++3++++++++++PLx+Pharma+Inc.+++++++++++For%3A+Apr+19++Filed+by%3A+MOSSMAN+GARY+L/12799155.html</guid>
   <pubDate>Thu, 20 Apr 2017 21:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DPRX</category>
   	  </item>
  <item>
   <title>Form  3          PLx Pharma Inc.           For: Apr 19  Filed by: JORDEN DAVID EMERSON</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++3++++++++++PLx+Pharma+Inc.+++++++++++For%3A+Apr+19++Filed+by%3A+JORDEN+DAVID+EMERSON/12799156.html</link>
   <description>si-local-file:///var/storage/secattach/20170420/12799156.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++3++++++++++PLx+Pharma+Inc.+++++++++++For%3A+Apr+19++Filed+by%3A+JORDEN+DAVID+EMERSON/12799156.html</guid>
   <pubDate>Thu, 20 Apr 2017 21:05:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DPRX</category>
   	  </item>
  <item>
   <title>Form  3          PLx Pharma Inc.           For: Apr 19  Filed by: Balkema Gary S.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++3++++++++++PLx+Pharma+Inc.+++++++++++For%3A+Apr+19++Filed+by%3A+Balkema+Gary+S./12799153.html</link>
   <description>si-local-file:///var/storage/secattach/20170420/12799153.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++3++++++++++PLx+Pharma+Inc.+++++++++++For%3A+Apr+19++Filed+by%3A+Balkema+Gary+S./12799153.html</guid>
   <pubDate>Thu, 20 Apr 2017 21:04:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DPRX</category>
   	  </item>
  <item>
   <title>Form  3          PLx Pharma Inc.           For: Apr 19  Filed by: HADDEN JOHN</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++3++++++++++PLx+Pharma+Inc.+++++++++++For%3A+Apr+19++Filed+by%3A+HADDEN+JOHN/12799154.html</link>
   <description>si-local-file:///var/storage/secattach/20170420/12799154.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++3++++++++++PLx+Pharma+Inc.+++++++++++For%3A+Apr+19++Filed+by%3A+HADDEN+JOHN/12799154.html</guid>
   <pubDate>Thu, 20 Apr 2017 21:04:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DPRX</category>
   	  </item>
  <item>
   <title>Form  3          PLx Pharma Inc.           For: Apr 19  Filed by: Casale Robert</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++3++++++++++PLx+Pharma+Inc.+++++++++++For%3A+Apr+19++Filed+by%3A+Casale+Robert/12799152.html</link>
   <description>si-local-file:///var/storage/secattach/20170420/12799152.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++3++++++++++PLx+Pharma+Inc.+++++++++++For%3A+Apr+19++Filed+by%3A+Casale+Robert/12799152.html</guid>
   <pubDate>Thu, 20 Apr 2017 21:03:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DPRX</category>
   	  </item>
  <item>
   <title>Form  3          PLx Pharma Inc.           For: Apr 19  Filed by: CALHOUN KIRK K</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++3++++++++++PLx+Pharma+Inc.+++++++++++For%3A+Apr+19++Filed+by%3A+CALHOUN+KIRK+K/12799151.html</link>
   <description>si-local-file:///var/storage/secattach/20170420/12799151.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++3++++++++++PLx+Pharma+Inc.+++++++++++For%3A+Apr+19++Filed+by%3A+CALHOUN+KIRK+K/12799151.html</guid>
   <pubDate>Thu, 20 Apr 2017 21:02:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DPRX</category>
   	  </item>
  <item>
   <title>Form  4          Dipexium Pharmaceuticals  For: Jan 17  Filed by: Shawah Robert G.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Dipexium+Pharmaceuticals++For%3A+Jan+17++Filed+by%3A+Shawah+Robert+G./12794731.html</link>
   <description>si-local-file:///var/storage/secattach/20170420/12794731.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Dipexium+Pharmaceuticals++For%3A+Jan+17++Filed+by%3A+Shawah+Robert+G./12794731.html</guid>
   <pubDate>Thu, 20 Apr 2017 06:31:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DPRX</category>
   	  </item>
  <item>
   <title>Form  4          Dipexium Pharmaceuticals  For: Jan 17  Filed by: McSherry, Jr. William J.</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Dipexium+Pharmaceuticals++For%3A+Jan+17++Filed+by%3A+McSherry%2C+Jr.+William+J./12794707.html</link>
   <description>si-local-file:///var/storage/secattach/20170420/12794707.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Dipexium+Pharmaceuticals++For%3A+Jan+17++Filed+by%3A+McSherry%2C+Jr.+William+J./12794707.html</guid>
   <pubDate>Thu, 20 Apr 2017 06:29:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DPRX</category>
   	  </item>
  <item>
   <title>Form  4          Dipexium Pharmaceuticals  For: Jan 17  Filed by: Kagan Barry</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Dipexium+Pharmaceuticals++For%3A+Jan+17++Filed+by%3A+Kagan+Barry/12794702.html</link>
   <description>si-local-file:///var/storage/secattach/20170420/12794702.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Dipexium+Pharmaceuticals++For%3A+Jan+17++Filed+by%3A+Kagan+Barry/12794702.html</guid>
   <pubDate>Thu, 20 Apr 2017 06:27:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DPRX</category>
   	  </item>
  <item>
   <title>Form  4          Dipexium Pharmaceuticals  For: Jan 17  Filed by: HARRISON THOMAS L</title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Dipexium+Pharmaceuticals++For%3A+Jan+17++Filed+by%3A+HARRISON+THOMAS+L/12794697.html</link>
   <description>si-local-file:///var/storage/secattach/20170420/12794697.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Dipexium+Pharmaceuticals++For%3A+Jan+17++Filed+by%3A+HARRISON+THOMAS+L/12794697.html</guid>
   <pubDate>Thu, 20 Apr 2017 06:24:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DPRX</category>
   	  </item>
 </channel>
</rss>
